These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21442520)

  • 1. Assessment of antitumor activity for tumor xenograft studies using exponential growth models.
    Wu J
    J Biopharm Stat; 2011 May; 21(3):472-83. PubMed ID: 21442520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing cytotoxic treatment effects in preclinical tumor xenograft models.
    Wu J; Houghton PJ
    J Biopharm Stat; 2009 Sep; 19(5):755-62. PubMed ID: 20183441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interval approach to assessing antitumor activity for tumor xenograft studies.
    Wu J; Houghton PJ
    Pharm Stat; 2010; 9(1):46-54. PubMed ID: 19306260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Prolongation Index as a Novel Metric to Assess Anti-Tumor Activity in Xenograft Models.
    Chandra F; Zaks L; Zhu A
    AAPS J; 2019 Jan; 21(2):16. PubMed ID: 30627814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New criteria for analyzing the statistical relationships between biological parameters and therapeutic responses of xenografted tumor models.
    Medioni J; Leuraud P; Delattre JY; Poupon MF; Golmard JL
    Contemp Clin Trials; 2012 Jan; 33(1):178-83. PubMed ID: 21986388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model to study the effects of drugs administration on tumor growth dynamics.
    Magni P; Simeoni M; Poggesi I; Rocchetti M; De Nicolao G
    Math Biosci; 2006 Apr; 200(2):127-51. PubMed ID: 16516246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
    Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
    Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new parameter of growth inhibition for cell proliferation assays.
    Fiorentino FP; Bagella L; Marchesi I
    J Cell Physiol; 2018 May; 233(5):4106-4115. PubMed ID: 29023715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors.
    Kurtzberg LS; Battle T; Rouleau C; Bagley RG; Agata N; Yao M; Schmid S; Roth S; Crawford J; Krumbholz R; Ewesuedo R; Yu XJ; Wang F; Lavoie EJ; Teicher BA
    Mol Cancer Ther; 2008 Oct; 7(10):3212-22. PubMed ID: 18852125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition.
    Gilmartin AG; Bleam MR; Groy A; Moss KG; Minthorn EA; Kulkarni SG; Rominger CM; Erskine S; Fisher KE; Yang J; Zappacosta F; Annan R; Sutton D; Laquerre SG
    Clin Cancer Res; 2011 Mar; 17(5):989-1000. PubMed ID: 21245089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
    Lundgren K; Zhang H; Brekken J; Huser N; Powell RE; Timple N; Busch DJ; Neely L; Sensintaffar JL; Yang YC; McKenzie A; Friedman J; Scannevin R; Kamal A; Hong K; Kasibhatla SR; Boehm MF; Burrows FJ
    Mol Cancer Ther; 2009 Apr; 8(4):921-9. PubMed ID: 19372565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
    Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
    Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-sample inference for incomplete longitudinal data with truncation and censoring in tumor xenograft models.
    Tan M; Fang HB; Tian GL; Houghton PJ
    Biometrics; 2002 Sep; 58(3):612-20. PubMed ID: 12229996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical synthesis, NMR analysis and evaluation on a cancer xenograft model (HL-60) of the aminosteroid derivative RM-133.
    Maltais R; Hospital A; Delhomme A; Roy J; Poirier D
    Steroids; 2014 Apr; 82():68-76. PubMed ID: 24486462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of oleandrin derivatives and their cytotoxic activity.
    Zhang Y; Chen X; Zhou Y; Hou J; Long H; Zhang Z; Lei M; Wu W
    Steroids; 2020 Jul; 159():108650. PubMed ID: 32360418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG.
    Hasenstein JR; Shin HC; Kasmerchak K; Buehler D; Kwon GS; Kozak KR
    Mol Cancer Ther; 2012 Oct; 11(10):2233-42. PubMed ID: 22896668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response.
    Zhao Z; Zhu J; Quan H; Wang G; Li B; Zhu W; Xie C; Lou L
    Oncotarget; 2016 May; 7(20):29648-63. PubMed ID: 27105490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval estimation of quantile ratios applied to anti-cancer drug screening by xenograft experiments.
    Cheng C; Wu J
    Stat Med; 2010 Nov; 29(26):2669-78. PubMed ID: 20799257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models.
    Lin J; Sampath D; Nannini MA; Lee BB; Degtyarev M; Oeh J; Savage H; Guan Z; Hong R; Kassees R; Lee LB; Risom T; Gross S; Liederer BM; Koeppen H; Skelton NJ; Wallin JJ; Belvin M; Punnoose E; Friedman LS; Lin K
    Clin Cancer Res; 2013 Apr; 19(7):1760-72. PubMed ID: 23287563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-cell targeting polydiacetylene micelles encapsulated with an antitumor drug for the treatment of ovarian cancer.
    Yao D; Li S; Zhu X; Wu J; Tian H
    Chem Commun (Camb); 2017 Jan; 53(7):1233-1236. PubMed ID: 27995230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.